BRISBANE, Calif.–(BUSINESS WIRE)–CUTERA, INC. (the “Company”) (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today acknowledged receipt of, and issued the following response to, a demand by J. Daniel Plants to call a special meeting of stockholders. In a letter dated April 3, 2023, Mr. Plants, in his capacity as Executive Chairman of … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#COVID19–AIDS Healthcare Foundation (AHF) marks World Health Day on April 7 by reminding world leaders and global public health institutions that a new Global Public Health Convention is still needed if the world is to be ready to prevent and respond effectively to future pandemics. “We’re more than three years removed from the … [Read more…]

MIAMI–(BUSINESS WIRE)–#biotech–The monoclonal antibodies (mAbs) daratumumab, and elotuzumab have been approved by the U.S. Food and Drug Administration for treating multiple myeloma (MM) in 2015. Although clinical responses have been promising, most patients’ disease eventually progresses [1]. One of the potential anti-tumor mechanisms of mAbs in MM patients is antibody-dependent cellular cytotoxicity (ADCC) which is … [Read more…]

STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, announced that its CertainT® supply chain traceability platform is featured in an article on the home page of the New York Times website today. The article, titled “How A.I. and DNA Are Unlocking the Mysteries of Global … [Read more…]

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), a company focused on developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that the Company and its wholly owned subsidiary, Pear Therapeutics (US), Inc. (collectively, the “Debtors”) each voluntarily filed for protection under chapter 11 (“Chapter 11”) of the U.S. Bankruptcy Code (the … [Read more…]

BOTHELL, Wash.–(BUSINESS WIRE)–Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023. Given the recently announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call. About Seagen Seagen is a global biotechnology company that discovers, develops and commercializes … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 66.2 Billion by 2028, exhibiting a CAGR … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and … [Read more…]

WESTMINSTER, Colo.–(BUSINESS WIRE)–Maxar Technologies (NYSE:MAXR) (TSX:MAXR), provider of comprehensive space solutions and secure, precise, geospatial intelligence, today announced that Intelsat 40e (IS-40e) is performing as expected after being launched aboard a SpaceX Falcon 9 rocket from Cape Canaveral Space Force Station in Florida. Shortly after launch earlier today, the satellite deployed its solar arrays and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Medical Device Studies: Regulatory Requirements and Adverse Event Reporting Training Course” conference has been added to ResearchAndMarkets.com’s offering. This seminar provides an essential overview of medical device clinical evaluations, clinical investigations and PMCF studies with particular emphasis on the adverse event reporting requirements during these studies. The course will concentrate mostly on the … [Read more…]